tirzepatide shortage news today is NO longer in SHORTAGE. What You Need to Know Eli Lilly's Weight-Loss Drug Zepbound

Is Triple Agonist Therapy Available Now

dpp-4_inhibitors DPP-4 Inhibitors Sitagliptin Trade Name: Januvia Drug Class: oral hypoglycemics Mechanism of Action: An inhibitor of dipeptidyl peptidase-4 (DPP-4), a protease that degrades the incretin GLP-1 Incretins are hormones released from the GI tract in response to nutrient ingestion Incretins potentiate glucose-stimulated insulin secretion from beta cells in the pancreas As a result of inhibiting DPP-4, increased or prolonged GLP-1 levels are able to potentiate the secretion of insulin by the pancreas The effect produced by DPP-4 inhibitors is dependent on endogenous GLP-1 levels, and produce a modest effect on GLP-1 activity compared to giving GLP-1 receptor agonists (hence DPP-4 inhibitors do not have the same impact to produce weight loss as GLP-1 agonists)

Studies indicate the prescription drug may also increase a persons risk of developing brain or spinal tumors

Understanding these patterns prevents discouragement during early phases when changes feel gradual compared to unrealistic expectations set by fad diets

That work isolated a protein from human gastric juice, named it Body Protection Compound (BPC), and defined partial sequences including the 15-amino-acid sequence later designated BPC-157